Literature DB >> 33749508

Circular RNA SMARCA5 functions as an anti-tumor candidate in colon cancer by sponging microRNA-552.

Shiwei Yang1,2,3,4, Shanyu Gao5, Tongming Liu6, Junning Liu1,2,3,4, Xia Zheng1,2,3,4, Zhi Li1,2,3,4.   

Abstract

It was reported that circular RNA (circRNA) circSMARCA5, as a tumor-related molecule, could modulate development of cancers, including prostatic cancer and cervical cancer. Nevertheless, the essential function of circSMARCA5 in colon cancer has not yet been confirmed. We aimed to investigate the role of circSMARCA5 in colon cancer. CircSMARCA5 expression in tumor cells was detected using RT-qPCR. CCK-8, colony formation, flow cytometry and Transwell assays evaluated the influences of circSMARCA5 in colon cancer cells. RT-qPCR, prediction database and luciferase report assay were accomplished for revealing the correlation between circSMARCA5 and miR-552. After transfection with miR-552 mimic, colon cancer cell behaviors were re-evaluated. Wnt and YAP1 pathways were explored by western blot. Our data presented that circSMARCA5 was under-expressed in colon cancer tissues. Transfection with overexpressing circSMARCA5 plasmid restrained growth, migration and invasion of colon cancer cells. Besides, circSMARCA5 directly sponged to miR-552 and miR-552 up-regulation offset the effects of circSMARCA5 on SW480 and SW620 cells. Furthermore, circSMARCA5 inactivated Wnt and YAP1 pathways by inhibiting miR-552. Anti-tumor role of sircSMARCA5 was showed in colon cancer cells as sponging miR-552 and blocking Wnt and YAP1 pathways.

Entities:  

Keywords:  Circular RNA SMARCA5; colon cancer; microrna-552; wnt pathway; yap1 pathway

Mesh:

Substances:

Year:  2021        PMID: 33749508      PMCID: PMC8078666          DOI: 10.1080/15384101.2021.1899519

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

1.  Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.

Authors:  N Wang; W Liu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-01       Impact factor: 3.507

2.  MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer.

Authors:  Jia Cao; Xiu-Rui Yan; Ting Liu; Xue-Bo Han; Jing-Jing Yu; Shi-Hai Liu; Li-Bin Wang
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

3.  Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.

Authors:  Jian Yu; Qing-Guo Xu; Zhen-Guang Wang; Yuan Yang; Ling Zhang; Jin-Zhao Ma; Shu-Han Sun; Fu Yang; Wei-Ping Zhou
Journal:  J Hepatol       Date:  2018-01-31       Impact factor: 25.083

4.  Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances.

Authors:  Xuning Wang; Yue Zhang; Liang Huang; Jiajin Zhang; Fei Pan; Bing Li; Yongfeng Yan; Baoqing Jia; Hongyi Liu; Shiyou Li; Wei Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

Review 5.  A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.

Authors:  Masahiro Shibata; Kendall Ham; Mohammad Obaidul Hoque
Journal:  Int J Cancer       Date:  2018-07-24       Impact factor: 7.396

6.  Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer.

Authors:  Zhe Kong; Xuechao Wan; Yalong Zhang; Pu Zhang; Yingyi Zhang; Xiaona Zhang; Xiaoxiang Qi; Hai Wu; Jianfeng Huang; Yao Li
Journal:  Biochem Biophys Res Commun       Date:  2017-07-29       Impact factor: 3.575

7.  Attributable causes of colorectal cancer in China.

Authors:  Meng-Jia Gu; Qiu-Chi Huang; Cheng-Zhen Bao; Ying-Jun Li; Xiao-Qin Li; Ding Ye; Zhen-Hua Ye; Kun Chen; Jian-Bing Wang
Journal:  BMC Cancer       Date:  2018-01-05       Impact factor: 4.430

8.  Circular RNA SMARCA5 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by miR-19b-3p/HOXA9 axis.

Authors:  Yaqiu Wang; Huiping Li; Hong Lu; Yaguang Qin
Journal:  Onco Targets Ther       Date:  2019-08-30       Impact factor: 4.147

Review 9.  The current status of treatment for colorectal cancer in China: A systematic review.

Authors:  Yumei Zhang; Zhiyu Chen; Jin Li
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

10.  CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.

Authors:  Davide Barbagallo; Angela Caponnetto; Matilde Cirnigliaro; Duilia Brex; Cristina Barbagallo; Floriana D'Angeli; Antonio Morrone; Rosario Caltabiano; Giuseppe Maria Barbagallo; Marco Ragusa; Cinzia Di Pietro; Thomas Birkballe Hansen; Michele Purrello
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

View more
  6 in total

Review 1.  The Emerging Roles of circSMARCA5 in Cancer.

Authors:  Haoyu Qin; Renhua Wan
Journal:  J Oncol       Date:  2022-06-07       Impact factor: 4.501

Review 2.  The Role of RNA in DNA Breaks, Repair and Chromosomal Rearrangements.

Authors:  Matvey Mikhailovich Murashko; Ekaterina Mikhailovna Stasevich; Anton Markovich Schwartz; Dmitriy Vladimirovich Kuprash; Aksinya Nicolaevna Uvarova; Denis Eriksonovich Demin
Journal:  Biomolecules       Date:  2021-04-09

Review 3.  The functional roles of the circRNA/Wnt axis in cancer.

Authors:  Chen Xue; Ganglei Li; Qiuxian Zheng; Xinyu Gu; Zhengyi Bao; Juan Lu; Lanjuan Li
Journal:  Mol Cancer       Date:  2022-05-05       Impact factor: 41.444

Review 4.  CircSMARCA5: A key circular RNA in various human diseases.

Authors:  Yi Zhu; Gaozhen Huang; Shihao Li; Hong Xiong; Ruiqi Chen; Ling Zuo; Hongwei Liu
Journal:  Front Genet       Date:  2022-08-23       Impact factor: 4.772

Review 5.  The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer.

Authors:  Changning Xue; Jianxia Wei; Mengna Li; Shipeng Chen; Lemei Zheng; Yuting Zhan; Yumei Duan; Hongyu Deng; Wei Xiong; Guiyuan Li; Hui Li; Ming Zhou
Journal:  Cells       Date:  2022-09-30       Impact factor: 7.666

6.  Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.

Authors:  Jianjia Xiao; Qingqing Liu; Weijie Wu; Ying Yuan; Jie Zhou; Jieyu Shi; Shaorong Zhou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.